In preparation for Brexit, the 27 EU Member States, together with the European Medicines Agency (EMA), have reached a major milestone in the EMA Transition Plan.  The EMA has confirmed the reallocation of rapporteurs for the centrally authorised medicinal...

In draft guidelines prepared by the President of the European Council, and published on 7 March 2018, the European Council has downplayed the likelihood of the United Kingdom staying in the regional regulatory network after Brexit. Previously, British Prime Minister...

We are on the home-straight to Brexit!  Just one year (30th March 2019), to the official date in which the United Kingdom will no longer be a member of the European Union. 
The 2nd Industry Stakeholder meeting on Brexit...

The current trading dynamic between the UK and EU, in the pharmaceutical sector, represents one of most integrated relationships of all the industry sectors.  Not only in terms of product trade, but also in terms of R&D,  legislative and regulatory...